NEW YORK (
) hit a new 52-week high Friday as it is currently trading at $85.98, above its previous 52-week high of $85.93 with 219,778 shares traded as of 10:16 a.m. ET. Average volume has been 1.4 million shares over the past 30 days.
Becton Dickinson has a market cap of $18.9 billion and is part of the
industry. Shares are up 1.2% year to date as of the close of trading on Thursday.
Becton, Dickinson and Company (BD), a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices for use in various healthcare settings. The company has a P/E ratio of 14.9, below the average health services industry P/E ratio of 15.4 and below the S&P 500 P/E ratio of 17.
- Practice your BDX trading strategies and win cash in our stock game.
TheStreet Ratings rates Becton Dickinson as a
. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share, notable return on equity, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full
52-week high stocks
or get investment ideas from our